Omnicyte, LLC
OmniCyte, LLC is a preclinical-stage biotechnology company based in Guilford, CT, dedicated to developing targeted treatments that address unmet needs in cancer therapy. The company is advancing its proprietary ImmunoOncology Platform Technology, which focuses on recombinant targeted immunomodulators and costimulators for various indications including ovarian cancer and small cell lung cancer.
With a strong management team and a board of renowned experts in oncology, epidemiology, and biochemistry, OmniCyte is positioned to make significant strides in the cancer treatment landscape. The company has secured funding through various sources, including Connecticut Innovations and translational research grants, to support its innovative research and development efforts.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.